Last reviewed · How we verify

NCT04791202

Hypertonic Dextrose Versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis

Status unknown Phase 3 Last updated 16 March 2021
What this trial tests

Phase 3 trial testing Dextrose in Pain in 130 participants. Status unknown.

Timeline
1 April 2021
Primary endpoint
1 March 2022
1 July 2022

Quick facts

Lead sponsorChristine M. Kleinert Institute for Hand and Microsurgery
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment130
Start date1 April 2021
Primary completion1 March 2022
Estimated completion1 July 2022

Drugs / interventions tested

Conditions studied

Sponsor

Christine M. Kleinert Institute for Hand and Microsurgery

Who can join

18 and older, any sex, with Pain or Satisfaction, Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The evolving reports form recent studies are creating a promise on the potential use of dextrose injections for treating arthritis and replacing current method of treating early osteoarthritis by corticosteroids by giving long standing effect and improving patients' symptoms and function. Over the past 5 years, an increasing number of level I and level II studies have emerged, examining the effect of intra-articular prolotherapy for the treatment of both hip and knee osteoarthritis. On the contrary, there is limited data in small joints, such as the temporomandibular joint.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dextrose

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Christine M. Kleinert Institute for Hand and Microsurgery trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04791202.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing